Apimeds Pharmaceuticals US (APUS) Free Cash Flow (2024 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Free Cash Flow came in at -$3.8 million in Q4 2025, down 3754.43% YoY from $105067.8 in Q4 2024, and down 119.57% on a QoQ basis from -$1.7 million in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Free Cash Flow (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 2 years of Free Cash Flow data on file, last reported at -$3.8 million in Q4 2025.
- Quarterly Free Cash Flow fell 3754.43% year-over-year to -$3.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.0 million (down 1122.83% YoY) and the FY2025 annual result came in at -$9.0 million, down 1124.65% from the prior year.
- Free Cash Flow slipped to -$3.8 million in Q4 2025, from -$1.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$20313.0 in Q1 2025 to a low of -$3.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Apimeds Pharmaceuticals US | 7.35 Mn | 7.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.84 Mn |
| Dec 31, 2025 | -3.84 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | -20,313.00 |
| Mar 31, 2025 | -20,313.00 |
| Dec 31, 2024 | -99,616.00 |
| Dec 31, 2024 | -99,616.00 |
| Sep 30, 2024 | -186,755.00 |
| Sep 30, 2024 | -186,755.00 |
| Jun 30, 2024 | -184,055.00 |
| Jun 30, 2024 | -184,055.00 |
| Mar 31, 2024 | -263,100.00 |
| Mar 31, 2024 | -263,100.00 |